Evommune, Inc. (EVMN) Stock Overview
Explore Evommune, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Evommune, Inc. (EVMN)
Key Financials
Key Financials
Market Cap
162.6M
P/E Ratio
-4.84
EPS (TTM)
$-10.14
ROE
-1.95%
EVMN Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Evommune, Inc. (NYSE: EVMN) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Evommune, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of EVMN on the NYSE shows an RSI of 33.45, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $11.43 for the NYSE listing.
Key metrics behind Evommune, Inc.'s NYSE-traded stock include a P/E ratio of -4.84 and a market capitalization of 162.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of EVMN on the NYSE.